|
    NRXP U.S.: Nasdaq

    NRX Pharmaceuticals Inc.

    NRXPUS
    Open
    Last Updated: Jan 28, 2022 1:43 p.m. EST Real time quote

    $ 3.0600

    0.2000 6.99%
    Previous Close
    $2.8600
    Advanced Charting
    Volume: 453.06K 65 Day Avg: 2.93M
    15% vs Avg
    2.8600 Day Range 3.1898
    2.8000 52 Week Range 64.1999

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    NRXP Overview

    Performance

    5 Day
    • -7.55%
    1 Month
    • -35.98%
    3 Month
    • -69.79%
    YTD
    • -35.98%
    1 Year
    • -94.79%

    Recent News

    NRx Pharmaceuticals Gets Positive Safety Report for Zyesami As Covid Treatment

    Read full story

    Dow, S&P 500 end at records Wednesday as stocks rally in final week of 2021

    NRx files new BTD request for COVID-19 treatment, after FDA declined previous request

    NRX Pharmaceuticals files Breakthrough Therapy Designation for Zyesami in patients at immediate risk of death from COVID-19

    NRx Pharmaceuticals Set to Begin Next Trial of Covid-19 Vaccine After Review of Earlier Results

    NRx Pharmaceuticals Gets FDA Review for Zyesami Manufacturing

    NRx shares jump 39% on new clinical data testing its experimental COVID-19 drug in the critically ill

    3 Under-the-Radar COVID Stocks

    on Motley Fool

    DTST Stock Alert: The Pro Sports Deal That Has Data Storage Shares Soaring Today

    on InvestorPlace.com

    WEJO Stock: 9 Things to Know About Wejo Group as Microsoft Deal Shines Light on the AV Player

    on InvestorPlace.com

    NRXP Stock Alert: The Covid-19 News Lifting NRx Pharmaceuticals Today

    on InvestorPlace.com

    RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?

    on InvestorPlace.com

    3 COVID Stocks That Could Double in 2022

    on Motley Fool

    3 Biotech Stocks That Could Double in 2022

    on Motley Fool

    Company News for Dec 30, 2021

    on Zacks.com

    NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?

    on InvestorPlace.com

    Is Gilead Sciences Stock a Buy Now?

    on Motley Fool

    Company News for Nov 30, 2021

    on Zacks.com

    Why NRx Pharmaceuticals Stock Soared Today

    on Motley Fool

    3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire

    on Motley Fool

    Why NRX Pharmaceuticals Stock Is Jumping Today

    on Motley Fool

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

    on InvestorPlace.com

    1 Small-Cap Stock With 10X Potential

    on Motley Fool

    2 Biotech Stocks Poised for Jaw-Dropping Growth

    on Motley Fool

    Why NRx Pharmaceuticals Stock Is Tumbling Today

    on Motley Fool

    TSM Stock: 10 Reasons Why Taiwan Semiconductor Investors Are Feeling Chipper Today

    on InvestorPlace.com

    Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday

    on Motley Fool

    NRX Pharmaceuticals Inc.

    NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.